<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03636542</url>
  </required_header>
  <id_info>
    <org_study_id>ANES-2018-26543</org_study_id>
    <nct_id>NCT03636542</nct_id>
  </id_info>
  <brief_title>Evaluation of Diaphragm Movement After an Interscalene Block</brief_title>
  <official_title>Evaluation of Diaphragm Movement After an Interscalene Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the movement of the diaphragm after an interscalene&#xD;
      block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine.&#xD;
      This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using&#xD;
      liposome bupivacaine in an interscalene block, using ultrasound.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be run concurrently with two other studies comparing bupivacaine to Liposomal&#xD;
      Bupivacaine in shoulder surgeries. We will use already randomized patients for our&#xD;
      randomization process. For this study in particular we will use an ultrasound machine to scan&#xD;
      the diaphragm of any patient who had an Interscalene Block for Total Shoulder Arthroplasy or&#xD;
      Rotator Cuff Repair. Patients are to be scanned in an upright sitting position and scanned&#xD;
      from a low intercostal or subcostal approach using the liver or spleen as an acoustic window.&#xD;
      M Mode will be applied and the range of diaphragmatic movement from the resting expiratory&#xD;
      position to deep inspiration (sigh test) will be recorded as was the range of diaphragmatic&#xD;
      movement from resting expiratory position when quickly inspiring through the nose (sniff&#xD;
      test). The blocks will be done regardless of the study as they are standard of care for pain&#xD;
      control. The only intervention is ultrasound examination of the patient's diaphragm at&#xD;
      baseline, 3 hours post block in recovery room and on post-operative day 1, and basic&#xD;
      spirometry to record FEV1 and FVC via a portable spirometer at the same time points. If&#xD;
      patients did stay in hospital on postoperative day 2 we would also evaluate their diaphragm&#xD;
      function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragm excursion with sigh</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of diaphragm excursion (movement in cm) from rest to sigh in a sitting position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragm excursion with quick inspiratory breath</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of diaphragm excursion (movement in cm) from rest to a quick inspiratory breath.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in 1 second (FEV1)</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FEV1 via spirometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced vital capacity (FVC)</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FVC via spirometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1/FVC ratio</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FEV1/FVC ratio via spirometry.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Phrenic Nerve Paralysis</condition>
  <arm_group>
    <arm_group_label>liposomal bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients receive an interscalene block with liposomal bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients receive an interscalene block with bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liposomal bupivacaine</intervention_name>
    <description>Experimental</description>
    <arm_group_label>liposomal bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>Active comparator</description>
    <arm_group_label>bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients age 18 years and older who are scheduled for shoulder surgery with&#xD;
             interscalene block and remain in the hospital for more than 24 hours that are being&#xD;
             randomized into a bupivacaine versus liposomal bupivacaine interscalene block study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non English speaking patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason habeck, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason Habeck, MD</last_name>
    <phone>612-624-9990</phone>
    <email>habe0073@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa Cohen</last_name>
    <phone>612-624-9990</phone>
    <email>Cohen045@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univeristy of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Cohen</last_name>
      <phone>612-625-7116</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>August 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

